Releases: monarch-initiative/mondo
Releases · monarch-initiative/mondo
v2023-03-01
Overview:
- Number of new terms: 43
- Number of changed labels: 10
- Number of changed definitions: 37
- Number obsoleted terms: 14
- Number of new obsoletion candidates: 8
- Number of terms who were previously candidate for obsoletion and are now not anymore: 2
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100009 | structural congenital heart disease, multiple types - GATA4 | Any congenital heart disease in which the cause of the disease is a mutation in the GATA4 gene. |
MONDO:0100042 | cardiac conduction defect | |
MONDO:0100117 | obsolete familial sudden death | OBSOLETE. An instance of sudden cardiac death that is caused by an inherited genomic modification in an individual. |
MONDO:0100118 | genetic skin disorder | An instance of skin disease that is caused by a modification of the individual's genome. |
MONDO:0100167 | pulmonary disease, chronic obstructive, susceptibility to | An inherited susceptibility or predisposition to developing COPD. |
MONDO:0100295 | Alzheimer disease, susceptibility to, mitochondrial | |
MONDO:0100511 | sudden cardiac arrest | The sudden loss of all heart activity due to an irregular heart rhythm. |
MONDO:0700049 | infectious disease, non-human animal | Infectious disease that occurs in non-human animals. |
MONDO:0700050 | bacterial infectious disease, non-human animal | Bacterial infectious disease that occurs in non-human animals. |
MONDO:0700053 | viral infectious disease, non-human animal | Viral infectious disease that occurs in non-human animals. |
MONDO:0700056 | fungal infectious disease, non-human animal | Fungal infectious disease that occurs in non-human animals. |
MONDO:0700058 | Morton neuroma | Compressive neuropathy of the forefoot interdigital nerve chiefly due to compression and irritation at the plantar aspect of the transverse intermetatarsal ligament. It is not a true neuroma as the condition is degenerative rather than neoplastic. The most common location for Morton neuroma is between the 2nd and 3rd metatarsals. |
MONDO:0700059 | Actinobacillus infectious disease, non-human animal | Actinobacillus infectious disease that occurs in non-human animals. |
MONDO:0700072 | Rhabdoviridae infectious disease, non-human animal | Rhabdoviridae infectious disease that occurs in non-human animals. |
MONDO:0700095 | Reoviridae infectious disease, non-human animal | Reoviridae infectious disease that occurs in non-human animals. |
MONDO:0700113 | Anaplasmataceae infectious disease, non-human animal | Anaplasmataceae infectious disease that occurs in non-human animals. |
MONDO:0700114 | vector-borne disease, non-human animal | Vector-borne disease that occurs in non-human animals. |
MONDO:0700201 | tick-borne infectious disease, non-human animal | Tick-borne infectious disease that occurs in non-human animals. |
MONDO:0700202 | Bunyaviridae infectious disease, non-human animal | Bunyaviridae infectious disease that occurs in non-human animals. |
MONDO:0700203 | pestivirus infectious disease, non-human animal | Pestivirus infectious disease that occurs in non-human animals. |
MONDO:0700204 | trichostrongyloidiasis, non-human animal | Trichostrongyloidiasis that occurs in non-human animals. |
MONDO:0700205 | ehrlichiosis, non-human animal | Ehrlichiosis that occurs in non-human animals. |
MONDO:0700206 | Parvoviridae infectious disease, non-human animal | Parvoviridae infectious disease that occurs in non-human animals. |
MONDO:0700207 | constitutional delay of growth and puberty | Transient state of hypogonadotropic hypogonadism associated with prolongation of childhood phase of growth, delayed skeletal maturation, delayed and attenuated pubertal growth spurt, and relatively low insulin-like growth factor-1 secretion. |
MONDO:0700208 | Caliciviridae infectious disease, non-human animal | Caliciviridae infectious disease that occurs in non-human animals. |
MONDO:0700209 | Strongylida infectious disease, non-human animal | Strongylida infectious disease that occurs in non-human animals. |
MONDO:0700210 | enterovirus infectious disease, non-human animal | Enterovirus infectious disease that occurs in non-human animals. |
MONDO:0700211 | Erysipelothrix infectious disease, non-human animal | Erysipelothrix infectious disease that occurs in non-human animals. |
MONDO:0700212 | tuberculosis, non-human animal | Tuberculosis that occurs in non-human animals. |
MONDO:0700213 | trypanosomiasis, non-human animal | Trypanosomiasis that occurs in non-human animals. |
MONDO:0700214 | Herpesviridae infectious disease, non-human animal | Herpesviridae infectious disease that occurs in non-human animals. |
MONDO:0700215 | NTRK fusion positive cancer | Neoplasm defined by the expression of a Neurotrophic Tyrosine Receptor Kinase (NTRK) Fusion. NTRK fusion-positive tumors have been identified in a broad range of solid tumor types, including breast, cholangiocarcinoma, colorectal, gynecological, neuroendocrine, non-small cell lung, salivary gland, pancreatic, sarcoma and thyroid cancers. |
MONDO:0700216 | RET fusion positive cancer | Neoplasm defined by the expression of a RET (REarranged during Transfection) fusion. |
MONDO:0700217 | neonatal sepsis | Bacterial infection in the bloodstream of newborn infants younger than 28 days old. |
MONDO:0700218 | group B streptococcal infection | A disease caused by infection with Group B Streptococcus. |
MONDO:0700219 | neoplastic meningitis | Metastatic neoplasm in which the tumor cells spread to leptomeninges (pia and arachnoid) and subarachnoid space. The most common primary tumors metastasizing to the leptomeninges are breast and lung carcinomas, melanoma, aggressive non-Hodgkin lymphoma, and acute lymphocytic leukemia. |
MONDO:0850001 | congenital neuronal ceroid lipofuscinosis | Congenital neuronal ceroid lipofuscinosis (CNCL) is a severe form of neuronal ceroid lipofuscinosis (NCL; see this term) with onset at birth characterized by primary microcephaly, neonatal epilepsy, and death in early infancy. |
MONDO:0850008 | anterior segment developmental abnormality with extraocular manifestations | |
MONDO:0850009 | syndromic microspherophakia | |
MONDO:0850010 | congenital optic disc excavation | |
MONDO:0850013 | twin anemia-polycythemia sequence | |
MONDO:0850014 | twin-reversed arterial perfusion sequence | |
MONDO:0850015 | selective intrauterine growth restriction |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000001 | disease | disease or disorder | disease |
MONDO:0003847 | hereditary disease | Mendelian disease | hereditary disease |
MONDO:0700096 | human disease | human disease or disorder | human disease |
MONDO:0007621 | Floating-Harbor syndrome | floating-Harbor syndrome | Floating-Harbor syndrome |
MONDO:0009263 | GAPO syndrome | gapo syndrome | GAPO syndrome |
MONDO:0009483 | Kapur-Toriello syndrome | kapur-Toriello syndrome | Kapur-Toriello syndrome |
MONDO:0009590 | metachromatic leukodystrophy due to saposin B deficiency | metachromatic leukodystrophy due to saposin b deficiency | metachromatic leukodystrophy due to saposin B deficiency |
MONDO:0011049 | Fine-Lubinsky syndrome | fine-Lubinsky syndrome | Fine-Lubinsky syndrome |
MONDO:0013166 | GABA aminotransaminase deficiency | GABA aminotransferase deficiency | GABA aminotransaminase deficiency |
MONDO:0015265 | bronchiolitis obliterans syndrome | bronchiolitis obliterans with obstructive pulmonary disease | bronchiolitis obliterans syndrome |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0005550 | infectious disease | A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. | A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent in humans. It can be transmitted by direct or indirect contact. |
MONDO:0007078 | pseudohypoparathyroidism type 1A | Pseudohypoparathyroidism type 1A (PHP1a) is a type of pseudohypoparathyroidism (PHP) characterized by renal resistance to parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and elevated PTH; resistance to other hormones including thydroid stimulating hormone (TSH), gonadotropins and growth-hormone-releasing hormone (GHRH); and a constellation of clinical features known as Albright hereditary osteodystrophy (AHO). | A type of pseudohypoparathyroidism (PHP) characterized by renal resistance to parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and elevated PTH; resistance to other hormones including thydroid stimulating hormone (TSH), gonadotropins and growth-hormone-releasing hormone (GHRH); and a constellation of clinical features known as Albright hereditary osteodystrophy (AHO). |
MONDO:0007412 | Beare-Stevenson cutis gyrata syndrome | Cutis Gyrata-Acanthosis nigricans-craniosynthosis also known as Beare-Stevenson syndrome (BSS) is a severe form of syndromic craniosynostosis, characterized by a variable degree of craniosynostosis, with cloverleaf skull reported in over 50% of cases, cutis gyrata, corduroy-like linear striations in the skin, acanthosis nigricans, skin tags, and choanal stenosis or atresia. Additional features include facial features similar to Crouzon disease, ear defects (conductive hearing loss, posteriorly angulated ears, stenotic auditory canals, preauricular furrows, and narrow ear canals), hirsutism, a prominent umbilical stump, and genitorurinary anomalies (anteriorly placed anus, hypoplasic labia, hypospadias). BSS is associated with a poor outcome as patients present an elevated risk for sudden death in their first year of life. Significant developmental delay an... |
v2023-02-06
Overview:
- Number of new terms: 17
- Number of changed labels: 11
- Number of changed definitions: 7
- Number obsoleted terms: 7
- Number of new obsoletion candidates: 22
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0031329 | craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome | |
MONDO:0031415 | Carey-Fineman-Ziter syndrome | |
MONDO:0031632 | developmental delay with short stature, dysmorphic facial features, and sparse hair | |
MONDO:0100158 | CHRNG-associated hypo-akinesia disorder of prenatal onset | A spectrum of presentations resulting from biallelic protein-altering variation in CHRNG. Inactivation of the receptor during early development leads to prenatal hypo-akinesia; subsequent phenotypes are a consequence of this hypo-akinesia and are thought to be dependent upon timing and severity of the anomaly at the neuromuscular junction. A range of phenotypes varying in severity (including both lethal and non-lethal presentations) have been reported, but typically include joint contractures, pterygia, dysmorphic features, vertebral and thoracic anomalies, and additional variable abnormalities. There are no clear genotype-phenotype correlations between the lethal and non-lethal presentations of this spectrum; both inter- and intra-familial variability have been reported, with the same variants being observed in both lethal and non-lethal cases. |
MONDO:0100190 | gastric intestinal metaplasia | Metaplastic changes in the lining of the upper digestive tract. |
MONDO:0100208 | self-limited familial neonatal-infantile epilepsy | An epilepsy syndrome associated with infantile period seizures, complete or nearly-complete seizure remission afterwards, usually good developmental outcome, and dominant transmission with high penetrance in pedigrees. For most affected infants, seizures begin within the first week after term birth. In a minority, however, seizures can begin after the first week but within the first several months of life. At onset, seizures may be highly recurrent, and often feature unilateral tonic limb stiffening that may alternate sides from seizure to seizure, accompanied by cyanosis and autonomic features. Limb shaking movements occur, but not in the evolving rhythmic pattern of tonic-clonic convulsions in older individuals. Neurological examination of the infant is normal between seizures. Although these seizures remit by 4-12 months of age in the majority, 15-30% of those affected have one or more seizure recurrences later, including febrile seizures, focal-onset seizures, and convulsions. Although most affected children show typical development, individuals with mild learning difficulties have been reported in families where the majority develop typically. |
MONDO:0100216 | DICER1-related tumor predisposition | Pathogenic germline variation in DICER1 confers an autosomal dominant predisposition to tumor formation at multiple primary sites, including pleuropulmonary blastoma, pulmonary cysts, thyroid gland neoplasia, ovarian tumors, and cystic nephroma. Other syndromic features such as macrocephaly have been described. |
MONDO:0100227 | ALS2-related motor neuron disease | Any motor neuron disease in which the cause of the disease is a mutation in the ALS2 gene. |
MONDO:0100235 | FOXC1-related anterior segment dysgenesis | Any anterior segment dysgenesis in which the cause of the disease is a mutation in the FOXC1 gene. |
MONDO:0100236 | LTBP2-related ocular dysgenesis | Any ocular dysgenesis disorder in which the cause of the disease is a mutation in the LTBP2 gene. |
MONDO:0100254 | CACNA1A-related complex neurodevelopmental disorder | A progressive complex neurodevelopmental condition caused by variants in the CACNA1A gene. Phenotypic onset (usually) occurs around age 1 and most often includes intellectual disability but can also include epileptic encephalopathy, benign paroxysmal torticollis of infancy and paroxysmal tonic upgaze psychomotor delay, learning difficulties, absence epilepsy, episodic ataxia, and hemiplegic migraines. |
MONDO:0700046 | baclofen withdrawal syndrome | Withdrawal syndrome involving the abrupt discontinuation of baclofen therapy (intrathecal or oral). Baclofen withdrawal syndrome can result in high fever, altered mental status (including agitation, insomnia, confusion, delusions, hallucinations, seizures, visual changes, or psychosis), and potentially profound muscular rigidity that sometimes progresses to fatal rhabdomyolysis. |
MONDO:0700047 | premenopausal osteoporosis | Osteoporosis occuring in premenopausal women with existing fragility fractures, diseases or treatments known to cause bone loss or fractures. |
MONDO:0700048 | hand-foot syndrome | A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents. |
MONDO:0800436 | craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 | Any craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development in which the cause of the disease is a variation in the TMCO1 gene. |
MONDO:0800437 | Carey-Fineman-Ziter syndrome 1 | A rare condition characterized by the association of hypotonia, Moebius sequence (bilateral congenital facial palsy with impairment of ocular abduction), Pierre-Robin sequence (micrognathia, glossoptosis, and high-arched or cleft palate), unusual face, and growth delay. |
MONDO:0800438 | developmental delay with short stature, dysmorphic facial features, and sparse hair 1 | Any developmental delay with short stature, dysmorphic facial features, and sparse hair in which the cause of the disease is a mutation in the DPH1 gene. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0013696 | chromosome 2p16.3 deletion syndrome | chromosome 2P16.3 deletion syndrome | chromosome 2p16.3 deletion syndrome |
MONDO:0021764 | acrofacial dysostosis Preis type | acrofacial dysostosis preis type | acrofacial dysostosis Preis type |
MONDO:0024773 | spermatogenic failure, X-linked, 4 | spermatogenic failure, x-linked, 4 | spermatogenic failure, X-linked, 4 |
MONDO:0025351 | multiple congenital anomalies-neurodevelopmental syndrome, X-linked | multiple congenital anomalies-neurodevelopmental syndrome, x-linked | multiple congenital anomalies-neurodevelopmental syndrome, X-linked |
MONDO:0035826 | symptomatic form of X-linked centronuclear myopathy in female carriers | symptomatic form of x-linked centronuclear myopathy in female carriers | symptomatic form of X-linked centronuclear myopathy in female carriers |
MONDO:0100024 | self-limited familial infantile epilepsy | self-limited familial and non-familial infantile seizures | self-limited familial infantile epilepsy |
MONDO:0800250 | Graves disease, susceptibility to, X-linked 2 | graves disease, susceptibility to, x-linked 2 | Graves disease, susceptibility to, X-linked 2 |
MONDO:0800318 | Emery-Deifuss muscular dystrophy 6, X-linked | Emery-dDeifuss muscular dystrophy 6, x-linked | Emery-Deifuss muscular dystrophy 6, X-linked |
MONDO:0800319 | cone dystrophy 5, X-linked | cone dystrophy 5, x-linked | cone dystrophy 5, X-linked |
MONDO:0800320 | cone dystrophy 1, X-linked | cone dystrophy 1, x-linked | cone dystrophy 1, X-linked |
MONDO:0800321 | congenital heart defects, multiple types, 1, X-linked | congenital heart defects, multiple types, 1, x-linked | congenital heart defects, multiple types, 1, X-linked |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0005567 | substance withdrawal syndrome | A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. | A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of a substance (including alcohol, prescribed medications and recreational drugs). Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. |
MONDO:0005789 | hepatitis D virus infection | Inflammation of the liver in humans caused by hepatitis delta virus, a defective rna virus that can only infect hepatitis B patients. For its viral coating, hepatitis delta virus requires the hepatitis B surface antigens produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. | Inflammation of the liver in humans caused by hepatitis delta virus, a defective RNA virus that can only infect hepatitis B patients. For its viral coating, hepatitis delta virus requires the hepatitis B surface antigens produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily trans... |
v2023-01-04
Overview:
- Number of new terms: 130
- Number of changed labels: 11
- Number of changed definitions: 11
- Number obsoleted terms: 9
- Number of new obsoletion candidates: 1
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100149 | PNPLA6-related spastic paraplegia with or without ataxia | An autosomal recessive, multisystem condition caused by pathogenic variants of the PNPLA6 gene that characterized by peripheral neuropathy, cognitive impairment, lower limb spasticity, muscle weakness, and reduced vibration sense. Additional clinical features may include cerebellar ataxia, hypogonadism, growth hormone deficiency, and hypothyroidism. |
MONDO:0100162 | IKBKG-related immunodeficiency with or without ectodermal dysplasia | Any recessive immunodeficiency (ID), with or without ectodermal dysplasia (EDA), in which the cause of the disease is mutation in the IKBKG gene. ID/EDA-ID patients, always males, are hemizygous for an IKBKG (NEMO) mutation that preserves residual NF-κB activation (hypomorphic mutations) and may also present with osteopetrosis and lymphoedema (OL-EDA-ID). |
MONDO:0100191 | inherited kidney disorder | A type of genetic disorder manifestations of primary clinical importance in the and that primarily results from alterations in one gene or from an alternation of the genome affecting one or more gene or functional element. Said genetic or genomic alteration may be inherited from one or both parents or may occur de novo. |
MONDO:0100198 | Mendelian encephalopathy | An instance of encephalopathy that is caused by an inherited genomic modification in an individual. |
MONDO:0100199 | diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate | |
MONDO:0100200 | microcephaly with intellectual disability | Microcephaly characterized by both microcephaly and atypical neurodevelopment, without other commonly reported non-brain related phenotypes. |
MONDO:0100201 | lumbar disc disease | A vertebral column disorder caused by degeneration of intervertebral discs of the lumbar spine. One of the most common musculoskeletal disorders, it has strong genetic determinants. |
MONDO:0100202 | lumbar disc herniation, susceptibility to | |
MONDO:0100206 | lumbar disc degeneration, susceptibility to | |
MONDO:0100207 | infantile-onset epilepsy | Epilepsy starting in the first 12 months of life, including self-limiting and refractory seizures, and epilepsies with and without developmental disorders. |
MONDO:0700042 | X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency | A susceptibility or predisposition to mycobacterial infectious diseases in which the cause of the disease is a mutation in the IKBKG gene. |
MONDO:0700044 | TUBB2A-related tubulinopathy | A tubulinopathy syndrome often associated with microtubule dysfunction, malformations of the corpus callosum, enlarged ventricles, dysgyria, abnormal basal ganglia, cerebellar vermis hypoplasia/dysplasia, and decreased white matter, due to heterozygous variants in TUBB2A. Individuals may present with variable combinations of malformations of the corpus callosum, enlarged ventricles, dysgyria, abnormal basal ganglia, cerebellar vermis hypoplasia/dysplasia, and decreased white matter. Epilepsy, speech impairment, and motor impairment are also frequent features. |
MONDO:0700045 | protothecosis | A disease caused by infection with achlorophyllic algae of the genus Prototheca, the majority caused by the species P. wickerhamii. Clinical manifestations of reported cases have included cutaneous lesions, olecranon bursitis, or systemic involvement. |
MONDO:0800296 | microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 | |
MONDO:0800297 | neuronal ceroid lipofuscinosis, late infantile | |
MONDO:0800298 | peroxisome biogenesis disorder, complementation group 2 | |
MONDO:0800299 | myopathy, congenital, with excess of muscle spindles | |
MONDO:0800300 | black locks with albinism and deafness syndrome | |
MONDO:0800301 | Friedreich ataxia with retained reflexes | |
MONDO:0800302 | glycogen storage disease Id | |
MONDO:0800303 | hypophosphatasia, perinatal lethal | |
MONDO:0800304 | neuropathy, hereditary sensory and autonomic, type IId | |
MONDO:0800305 | myelofibrosis with myeloid metaplasia | |
MONDO:0800306 | epilepsy, progressive myoclonic, 2b | |
MONDO:0800307 | de la Chapelle dysplasia | |
MONDO:0800308 | orotic aciduria without megaloblastic anemia | |
MONDO:0800310 | pregnancy loss, recurrent, 4 | |
MONDO:0800311 | vas deferens, congenital unilateral aplasia of | |
MONDO:0800312 | woolly hair, autosomal recessive 1, with or without hypotrichosis | |
MONDO:0800316 | contiguous ABCD1/DXS1375E deletion syndrome | |
MONDO:0800317 | premature ovarian failure 4 | |
MONDO:0800318 | Emery-dDeifuss muscular dystrophy 6, x-linked | |
MONDO:0800319 | cone dystrophy 5, x-linked | |
MONDO:0800320 | cone dystrophy 1, x-linked | |
MONDO:0800321 | congenital heart defects, multiple types, 1, x-linked | |
MONDO:0800322 | membranous obstruction of inferior vena cava | |
MONDO:0800323 | long QT syndrome 4 | |
MONDO:0800324 | microphthalmia, isolated, with coloboma 8 | |
MONDO:0800326 | cone-rod dystrophy 14 | |
MONDO:0800329 | febrile seizures, familial, 3a | |
MONDO:0800330 | myoclonic epilepsy, juvenile, 2 | |
MONDO:0800331 | hyperglycinemia, transient neonatal | |
MONDO:0800335 | migraine, familial hemiplegic, 4 | |
MONDO:0800337 | acute tubulointerstitial nephritis | |
MONDO:0800339 | laryngospasm, severe neonatal episodic | |
MONDO:0800340 | seasonal affective disorder, susceptibility to | |
MONDO:0800341 | cap myopathy 1 | |
MONDO:0800342 | cap myopathy 2 | |
MONDO:0800343 | rhegmatogenous retinal detachment, autosomal dominant | |
MONDO:0800344 | brachydactyly-syndactyly-oligodactyly syndrome | |
MONDO:0800345 | atrial fibrillation, familial, 17 | |
MONDO:0800346 | left ventricular noncompaction 9 | |
MONDO:0800347 | cardiomyopathy, familial hypertrophic, 23, with or without ventricular noncompaction | |
MONDO:0800349 | atrial fibrillation, familial, 16 | |
MONDO:0800350 | left ventricular noncompaction 4 | |
MONDO:0800408 | urogenital adysplasia | |
MONDO:0800409 | ventricular fibrillation during myocardial infarction, susceptibility to | |
MONDO:0800410 | UV-induced skin damage, susceptibility to | |
MONDO:0800412 | yakut short stature syndrome | |
MONDO:0800413 | antisocial behavior, susceptibility to | |
MONDO:0800414 | aplastic anemia, susceptibility to | |
MONDO:0800415 | asthma, aspirin-induced, susceptibility to | |
MONDO:0800416 | autism, susceptibility to, 1 | |
MONDO:0800417 | autism, susceptibility to, 4 | |
MONDO:0800418 | breast cancer, familial, susceptibility to, 1 | |
MONDO:0800419 | breast cancer, familial, susceptibility to, 2 | |
MONDO:0800420 | breast cancer, familial, susceptibility to, 3 | |
MONDO:0800421 | cardiomyopathy, familial hypertrophic, 4, susceptibility to | |
MONDO:0800422 | cirrhosis, noncryptogenic, susceptibility to | |
MONDO:0800423 | colorectal cancer, susceptibility to, 4 | |
MONDO:0800424 | colorectal cancer, susceptibility to, on chromosome 15 | |
MONDO:0800425 | coronary artery disease, severe, susceptibility to | |
MONDO:0800426 | dengue fever, susceptibility to | |
MONDO:0800427 | dengue hemorrhagic fever, susceptibility to | |
MONDO:0800428 | dengue shock syndrome, susceptibility to | |
MONDO:0800429 | dyslexia, susceptibility to, 4 | |
MONDO:0800430 | dyslexia, susceptibility to, 7 | |
MONDO:0800431 | efavirenz central nervous system toxicity, susceptibility to | |
MONDO:0800432 | obesity, susceptibility to | |
MONDO:0800433 | ovarian cancer, familial, susceptibility to, 1 | |
MONDO:0800434 | ovarian cancer, familial, susceptibility to, 2 | |
MONDO:0800435 | ovarian cancer, familial, susceptibility to, 3 | |
MONDO:0850030 | complete hemimelia | |
MONDO:0850046 | amniotic fluid embolism | |
MONDO:0850048 | classic eosinophilic pustular folliculitis | |
MONDO:0850049 | painful legs and moving toes syndrome | |
MONDO:0850050 | congenital aphakia-iris hypoplasia-microphthalmia-microcornea syndrome | |
MONDO:0850053 | F12-associated cold autoinflammatory syndrome | |
MONDO:0850054 | hemophilia B leyden | |
MONDO:0850058 | chronic neurovisceral acid sphingomyelinase deficiency | |
MONDO:0850059 | hereditary persistence of fetal hemoglobin-intellectual disability syndrome | |
MONDO:0850064 | inherited hematologic cancer-predisposing syndrome | |
MONDO:0850065 | neonatal-onset severe multisystemic autoinflammatory disease with increased IL18 | |
MONDO:0850066 | SAMD9L-associated autoinflammatory syndrome | |
MONDO:0850067 | immune deficiency due to impaired neutrophil phagocytosis and migration | |
MONDO:0850068 | early-onset autoimmunity-autoinflammation-immunodeficiency syndrome | |
MONDO:0850069 | familial hyperinflammatory lymphoproliferative immunodeficiency | |
MONDO:0850070 | CADINS disease | |
MONDO:0850071 | developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome | |
MONDO:0850072 | non-syndromic unisutural craniosynostosis | |
MONDO:0850073 | non-syndromic unicoronal craniosynostosis | |
MONDO:0850074 | non-syndromic unilambdoid craniosynostosis | |
MONDO:0850075 | non-syndromic unifrontosphenoidal craniosynostosis | |
MONDO:0850076 | non-syndromic unisquamosal craniosynostosis | |
MONDO:0850077 | non-syndromic multisutural craniosynostosis | |
MONDO:0850078 | non-syndromic non-specific multisutural craniosynostosis | |
MONDO:0850079 | non-syndromic bilambdoid craniosynostosis | |
... |
v2022-12-01
Overview:
- Number of new terms: 160
- Number of changed labels: 29
- Number of changed definitions: 25
- Number obsoleted terms: 3
- Number of new obsoletion candidates: 7
- Number of terms who were previously candidate for obsoletion and are now not anymore: 11
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0029465 | intellectual developmental disorder, autosomal dominant 69 | |
MONDO:0030805 | spinocerebellar ataxia 49 | |
MONDO:0030957 | developmental and epileptic encephalopathy 103 | |
MONDO:0030958 | dystonia 35, childhood-onset | |
MONDO:0030964 | intellectual developmental disorder, autosomal dominant 67 | |
MONDO:0030968 | intellectual developmental disorder, autosomal recessive 76 | |
MONDO:0030969 | intellectual developmental disorder, autosomal dominant 68 | |
MONDO:0030970 | immunodeficiency 106, susceptibility to viral infections | |
MONDO:0030972 | spermatogenic failure 74 | |
MONDO:0030975 | premature ovarian failure 20 | |
MONDO:0030983 | Waardenburg syndrome, IIa 2F | |
MONDO:0030984 | spermatogenic failure 75 | |
MONDO:0030993 | Tessadori-Van Haaften neurodevelopmental syndrome 3 | |
MONDO:0031000 | Tessadori-Van Haaften neurodevelopmental syndrome 4 | |
MONDO:0031019 | spastic paraplegia 87, autosomal recessive | |
MONDO:0031021 | developmental and epileptic encephalopathy 104 | |
MONDO:0031028 | developmental and epileptic encephalopathy 105 with hypopituitarism | |
MONDO:0031030 | immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection | |
MONDO:0031031 | intellectual developmental disorder, autosomal recessive 77 | |
MONDO:0031040 | cholestasis, progressive familial intrahepatic, 12 | |
MONDO:0031043 | lymphatic malformation 12 | |
MONDO:0031044 | advance sleep phase syndrome, familial, 4 | |
MONDO:0031045 | arthrogryposis, distal, IIa 11 | |
MONDO:0031047 | stickler syndrome, IIa 6 | |
MONDO:0031052 | developmental and epileptic encephalopathy 106 | |
MONDO:0031054 | ciliary dyskinesia, primary, 48, without situs inversus | |
MONDO:0031055 | developmental and epileptic encephalopathy 107 | |
MONDO:0031057 | dyskeratosis congenita, digenic | |
MONDO:0031060 | microcephaly 29, primary, autosomal recessive | |
MONDO:0031061 | nephrotic syndrome, IIa 26 | |
MONDO:0031062 | polycystic kidney disease 7 | |
MONDO:0031068 | charcot-marie-tooth disease, axonal,IIa 2II | |
MONDO:0031071 | diamond-blackfan anemia 21 | |
MONDO:0031077 | spermatogenic failure 76 | |
MONDO:0031083 | spermatogenic failure 77 | |
MONDO:0031084 | amelogenesis imperfecta, IIa 1K | |
MONDO:0031166 | macular dystrophy, retinal | |
MONDO:0031240 | familial panic disorder | |
MONDO:0031323 | cardiac valvular defect | |
MONDO:0031422 | familial mucolipidosis | |
MONDO:0031520 | familial severe combined immunodeficiency | |
MONDO:0031615 | familial bent bone dysplasia syndrome | |
MONDO:0031646 | Braddock-Carey syndrome | |
MONDO:0100049 | narcolepsy, susceptibility to | An inherited susceptibility or predisposition to developing narcolepsy. |
MONDO:0100098 | dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive | A dopa-responsive dystonia characterized by marked motor delay, but no intellectual disablity, and only minimal, if any, hyperphenylalaninemia. |
MONDO:0100119 | Knobloch syndrome 2 | |
MONDO:0100122 | UDP-N-acetylglucosamine-1-phosphotransferase subunit alpha/beta deficiency | An autosomal recessive mucolipidosis disorder caused by bi-allelic variants in the GNPTAB gene. Symptoms of this condition occur across a clinical spectrum including mucolipidosis type II (ML II) and mucolipidosis type III alpha/beta (ML IIIα/β), and phenotypes intermediate between ML II and ML IIIα/β. |
MONDO:0100123 | toxic bronchiolitis | Bronchiolitis as a response to a toxic exposure. |
MONDO:0100127 | toxic bronchiolitis obliterans | Toxic bronchiolitis whereby a biospy has shown an obliteration of broncioles. |
MONDO:0100153 | tubulinopathy | A nervous system disorder characterized by complex cortical malformations including in most cases dysmorphic basal ganglia in which the cause of the disease is a variation in one or more of the tubulin genes. |
MONDO:0100154 | TUBB3-related tubulinopathy | A tubulinopathy syndrome associated with malformations of cortical development, axon guidance defects, white matter abnormalities, and/or congenital fibrosis of the extraocular muscles (CFEOM), due to de novo or dominantly inherited variants with high penetrance. Individuals may present with variable combinations of malformations of cortical development, dysplasia of the basal ganglia, brainstem, and/or cerebellum, CFEOM, additional cranial nerve involvement, Kallmann syndrome, cyclic vomiting, peripheral neuropathy, and/or contractures. Developmental delays, intellectual disability, ocular motor apraxia, and mirror movements are also frequent features. |
MONDO:0100155 | retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome | An autosomal recessive, multisystem condition caused by pathogenic variants of the PNPLA6 gene, encoding the patatin like phospholipase domain containing 6 protein. RAPH syndrome is characterized by hypogonadism, cerebellar ataxia, retinal dystrophy, peripheral neuropathy, growth hormone deficiency, and cognitive impairment. Additional clinical features may include lower limb spasticity, trichomegaly, alopecia, and facial dismorphism. The term lumps Boucher-Neuhauser, Gordon Holmes, Laurence-Moon, and Oliver-McFarlene syndromes. |
MONDO:0100159 | pulmonary hypertension, neonatal | Abnormally high blood pressure in a newborn child. |
MONDO:0100166 | PPP2R1A-related intellectual disability | Any intellectual disability in which the cause of the disease is a mutation in the PPP2R1A gene. |
MONDO:0100168 | desmoid tumor caused by somatic mutation | |
MONDO:0100169 | polyneuropathy, inflammatory demyelinating, chronic | |
MONDO:0100170 | restless legs syndrome, susceptibility to | An inherited susceptibility or predisposition to developing restless legs syndrome. |
MONDO:0100171 | psoriasis, susceptibility to | An inherited susceptibility or predisposition to developing psoriasis. |
MONDO:0100173 | leukemia, acute myeloid, susceptibility to | An inherited susceptibility or predisposition to developing leukemia, acute myeloid. |
MONDO:0100174 | age related macular degeneration, susceptibility to | An inherited susceptibility or predisposition to developing age related macular degeneration. |
MONDO:0100177 | allergic rhinitis, susceptibility to | An inherited susceptibility or predisposition to developing allergic rhinitis. |
MONDO:0100178 | dermatitis, atopic, susceptibility to | An inherited susceptibility or predisposition to developing atopic dermatitis. |
MONDO:0100179 | Hirschsprung disease, susceptibility to | An inherited susceptibility or predisposition to developing Hirschsprung disease. |
MONDO:0100180 | diabetes mellitus, ketosis-prone | An inherited susceptibility or predisposition to developing diabetes mellitus, ketosis. |
MONDO:0100181 | dermatitis, atopic, 1 | An inherited susceptibility or predisposition to developing atopic dermatitis. A genomewide linkage study revealed highly significant evidence for linkage on 3q21 (ATOD1) at marker D3S3606. |
MONDO:0100182 | schizophrenia, susceptibility to | An inherited susceptibility or predisposition to developing schizophrenia. |
MONDO:0100183 | radioulnar synostosis, nonsyndromic, susceptibility to | A susceptibility or predisposition to radioulnar synostosis in which the cause of the disease is a mutation in the SMAD6 gene. |
MONDO:0100187 | opioid-induced constipation | A constipation disorder caused by use of opiods. OIC may present immediately when a patient takes the opioid, or it may present gradually during opioid therapy. |
MONDO:0100501 | body-stalk anomaly | A very rare anomaly (1 in 14,000 to 42,000 pregnancies; 1 in 7500 fetuses from 10 to 14 weeks of gestation) characterized by a complex anomaly of the anterior abdominal wall, severe kyphoscoliosis, rudimentary umbilical cord, and anatomical defects of the pelvis and lower limbs. |
MONDO:0700115 | proliferative vitreoretinopathy | Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes. |
MONDO:0700116 | microcephaly with lissencephaly and/or hydranencephaly | A brain disorder caused by biallelic variants in NDE1 that is characterized by extreme microcephaly (typically head circumference of more than 10 standard deviations (SD) below the mean), profound motor and intellectual disability, spasticity, and incomplete cerebral formation. Radiologic studies demonstrate overt microcephaly with cortical dysgenesis ranging from simplification to pachygyria/lissencephaly to hydranencephaly. Agenesis of the corpus callosum as well as hypoplasia of the brainstem and cerebellum are typically present. |
MONDO:0700117 | SLC6A3-related dopamine transporter deficiency syndrome | A complex movement disorder characterized by tremor, rigidity, bradykinesia, chorea, reduced facial expression, and Parkinsonism-dystonia. This disease is caused by loss of function variants in the SLC6A3 gene, which impair the dopamine transporter protein. The onset of this disease ranges from infancy to adulthood. |
MONDO:0700200 | atypical dopamine transporter deficiency syndrome | A subset of SLC6A3-related DTDS cases which have later onset which ranges from late childhood to adulthood. This disorder ... |
v2022-11-01
Overview:
- Number of new terms: 71
- Number of changed labels: 0
- Number of changed definitions: 3
- Number obsoleted terms: 3
- Number of new obsoletion candidates: 1
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100048 | graft-versus-host disease, susceptibility to | An inherited susceptibility or predisposition to developing graft vs. host disease. |
MONDO:0700112 | heterotaxy, visceral, 5, autosomal | Any visceral hetetotaxy in which the cause of the disease is a mutation in the NODAL gene. |
MONDO:0700131 | sarcoma, non-human animal | Sarcoma that occurs in non-human animals. |
MONDO:0700132 | melanoma, non-human animal | Melanoma that occurs in non-human animals. |
MONDO:0700133 | adenoma, non-human | Adenoma that occurs in non-human animals. |
MONDO:0700134 | bovine neoplasm | A neoplasm that occurs in cattle. |
MONDO:0700135 | bovine leukemia | A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood which occurs in cattle |
MONDO:0700136 | bovine protoporphyria | A congenital metabolic disorder characterized by a deficiency in the enzyme ferrochelatase, which occurs in cattle. |
MONDO:0700137 | bovine lymphosarcoma | Lymphosarcoma that occurs in a cow. |
MONDO:0700138 | bovine rectal myxoma | A myxoma that occurs in the rectum of a cow. |
MONDO:0700139 | canine neoplasm | A neoplasm that occurs in dogs. |
MONDO:0700140 | canine osteosarcoma | An osteosarcoma of mesenchymal origin in a dog. It is the most common bone cancer in dogs, most often developing in the limbs of large or giant breed dogs. The morphologic and biologic behavior of canine osteosarcomas is similar to that of human osteosarcomas. |
MONDO:0700141 | canine melanoma | Melanoma occurring in a dog. It is the most common malignant tumor found in the mouths of dogs and also occurs frequently on the digits. All canine melanomas are locally invasive and malignant canine melanomas show a high rate of metastasis. Melanoma in dogs has been established as a relevant model for human melanoma. |
MONDO:0700142 | canine hemangiosarcoma | Hemangiosarcoma occurring in a dog. It is an incurable tumor of vascular endothelial cells and occurs more commonly in dogs beyond middle age, and is especially common in certain breeds. Most hemangiosarcomas do not have a known cause. |
MONDO:0700143 | canine mammary carcinoma | Mammary carcinoma occurring in a dog. |
MONDO:0700144 | canine leukemia | An acute or chronic malignant (clonal) hematologic disorder, arising from hematopoietic stem cells in dogs. It is characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. |
MONDO:0700145 | canine lymphoma | A malignant lymphoproliferative disorder that affects dogs. It is characterized by the clonal proliferation of B- or T-lymphocytes in the lymph nodes, bone marrow, and/or extranodal sites. |
MONDO:0700146 | canine prostate carcinoma | A malignant epithelial neoplasm arising from the prostate gland of a dog. |
MONDO:0700147 | canine histiocytic sarcoma | A malignant neoplasm that affects dogs, characterized by the presence of malignant cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. |
MONDO:0700148 | canine transitional cell carcinoma | A malignant neoplasm that affects dogs, arising from transitional epithelium. |
MONDO:0700149 | canine sarcoma | A malignant mesenchymal neoplasm that affects dogs. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. |
MONDO:0700150 | canine mastocytoma | A tumor composed of mast cells that occurs in dogs. |
MONDO:0700151 | canine glioma | A brain or spinal cord tumor arising from glial cells that occurs in dogs. |
MONDO:0700152 | canine hepatocellular carcinoma | A malignant tumor arising from hepatocytes that occurs in dogs. |
MONDO:0700153 | canine lung adenocarcinoma | A carcinoma that arises from the lung in dogs and is characterized by the presence of malignant glandular epithelial cells. |
MONDO:0700154 | canine rhabdomyosarcoma | A malignant mesenchymal neoplasm arising from skeletal muscle that occurs in dogs. |
MONDO:0700155 | canine thyroid adenocarcinoma | Adeonocarcinoma of the thyroid gland occurring in a dog. |
MONDO:0700156 | canine soft tissue sarcoma | Soft tissue sarcoma occurring in a dog. |
MONDO:0700157 | canine oral squamous cell carcinoma | Oral squamous cell carcinoma that occurs in a dog. |
MONDO:0700158 | canine pancreatic carcinoma | Pancreatic carcinoma that occurs in a dog. |
MONDO:0700159 | canine acanthomatous epulis | A tumor arising from odontogenic epithelium and occurs in a dog. |
MONDO:0700160 | canine mammary adenoma | An adenoma arising from the mammary gland of a dog. |
MONDO:0700161 | canine gastrointestinal stromal tumor | A gastrointestinal stromal tumor occurring in a dog. |
MONDO:0700162 | canine granular cell tumor | A granular cell tumor occurring in a dog. |
MONDO:0700163 | canine Langerhans cell histiocytosis | Langerhans cell histiocytosis occurring in a dog. |
MONDO:0700164 | canine nephroblastoma | A nephroblastoma occurring in a dog. |
MONDO:0700165 | canine thyroid gland medullary carcinoma | Thyroid gland medullary carcinoma occurring in a dog. |
MONDO:0700166 | canine transmissible venereal tumor | A sexually transmitted tumor arising from histiocytes and occurring in dogs. |
MONDO:0700167 | canine sebaceous gland epithelioma | Sebaceous epithelioma occurring in a dog. |
MONDO:0700168 | canine oral melanoma | A melanoma that affects the lip and/or oral cavity of a dog. |
MONDO:0700169 | canine cutaneous t-cell lymphoma | Cutaneous T-cell lymphoma occurring in a dog. |
MONDO:0700170 | equine neoplasm | Neoplasm that occurs in a horse. |
MONDO:0700171 | horse melanoma | Melanoma that occurs in a horse. |
MONDO:0700172 | horse lymphoma | Lymphoma that occurs in a horse. |
MONDO:0700173 | horse sarcoid | A fibroblastic tumor that occurs in the skin of a horse. |
MONDO:0700174 | horse transitional cell carcinoma | Transitional cell carcinoma that occurs in a horse. |
MONDO:0700175 | feline neoplasm | Neoplasm that occurs in a cat. |
MONDO:0700176 | feline lymphoma | A lymphoma that occurs in cats. It is associated with exposure to feline leukemia virus and feline immunodeficiency virus. |
MONDO:0700177 | feline mammary carcinoma | Mammary carcinoma occurring in a cat. |
MONDO:0700178 | feline oral squamous cell carcinoma | Oral squamous cell carcinoma that occurs in a cat. |
MONDO:0700179 | feline osteosarcoma | Osteosarcoma that occurs in a cat. |
MONDO:0700180 | feline bronchioloalveolar lung carcinoma | Bronchioloalveolar lung carcinoma that occurs in a cat. |
MONDO:0700181 | feline fibrosarcoma | Fibrosarcoma that occurs in a cat. |
MONDO:0700182 | feline erythroleukemia | Erythroleukemia that occurs in a cat. |
MONDO:0700183 | feline reticulum cell sarcoma | Reticulum cell sarcoma that occurs in a cat. |
MONDO:0700184 | feline large granular lymphocyte lymphoma | A T-cell leukemia in which there is a persistent increase in the number of large granular lymphocytes in the peripheral blood and occurring in a cat. |
MONDO:0700185 | feline melanoma | A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that occurs in a cat. |
MONDO:0700186 | feline histiocytic sarcoma | Histiocytic sarcoma occurring in a cat. |
MONDO:0700187 | feline progressive histiocytosis | A condition occurring in cats characterized by solitary or multiple cutaneous nodules and papules, which may metastasize late in the course of the disease. Lesions consist of poorly circumscribed histiocytic infiltrates of the superficial and deep dermis, with variable extension into the subcutis. |
MONDO:0700188 | feline synovial cell sarcoma | Synovial cell sarcoma occurring in a cat. |
MONDO:0700189 | chicken neoplasm | A neoplasm that occurs in a chicken. |
MONDO:0700190 | chicken bursal lymphoma | A malignant lymphoma that arises in the bursa of Fabricius in a chicken. |
MONDO:0700191 | chicken fibrosarcoma | Fibrosarcoma that occurs in a chicken. |
MONDO:0700192 | chicken hepatoma | Hepatoma that occurs in a chicken. |
MONDO:0700193 | chicken monocytic leukemia | Monocytic leukemia that occurs in a chicken. |
MONDO:0700194 | chicken lymphoma | Lymphoma that occurs in a chicken. |
MONDO:0700195 | rous sarcoma | A fibrosarcoma, originally observed in a Plymouth Rock hen, now thought to be an expression of infection by certain viruses of the avian leukosis-sarcoma complex in the family |
MONDO:0700196 | fish melanoma | Melanoma that occurs in a fish. |
MONDO:0700197 | porcine leukemia | Leukemia that occurs in a pig. |
MONDO:0700198 | porcine lymphoma | Lymphoma that occurs in a pig. |
MONDO:0700199 | sheep lung adenocarcinoma | Adenocarcinoma arising from the lung of a sheep. |
Changed terms
No changed labels.
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0009821 | lethal osteosclerotic bone dysplasia | Lethal osteosclerotic bone dysplasia is defined by generalized osteosclerosis with periosteal bone formation, characteristic facial dysmorphism, brain abnormalities including intracerebral calcifications, and neonatal lethal course. | Generalized osteosclerosis with periosteal bone formation, characteristic facial dysmorphism, brain abnormalities including intracerebral calcifications, and neonatal lethal course. |
MONDO:0013730 | graft versus host disease | Acute graft-versus-host disease ... |
v2022-10-11
Overview:
- Number of new terms: 38
- Number of changed labels: 4
- Number of changed definitions: 69
- Number obsoleted terms: 6
- Number of new obsoletion candidates: 3
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100043 | epidermodysplasia verruciformis, susceptibility to | |
MONDO:0100045 | epidermodysplasia verruciformis, susceptibility to, 1 | |
MONDO:0100046 | exfoliation syndrome, susceptibility to | An inherited susceptibility or predisposition to developing exfoliation syndrome. |
MONDO:0100047 | basal cell carcinoma, susceptibility to | An inherited susceptibility or predisposition to developing basal cell carcinoma. |
MONDO:0800109 | persistent tachypnoe of infancy | A interstial lung disease characterized by the presence of persistent or intermittent tachypnea (usually noticed in neonatal period or after an acute infection for the first time in first months of life), crackles in 86 %, retractions in 82%, failure to thrive in 66%, chest wall abnormalities in 22% and hypoxemia or desaturation in 88%. |
MONDO:0800110 | persistent tachypnoe of infancy, aberrant | Persistent tachypnoe of infancy that presents with additional minor abnormalities upon scanning, including ground-glass opacities in other locations, focal consolidations, parenchymal cysts or bronchial wall thickening (N=80; 37%). |
MONDO:0800111 | persistent tachypnoe of infancy, usual | Persistent tachypnoe of infancy that presents with with no other airway or parenchymal abnormalities upon scanning (N=80; 63%). |
MONDO:0800112 | non-atopic asthma | A type of asthma that isn't related to an allergy trigger like pollen or dust, and is less common than atopic asthma. |
MONDO:0800113 | necrotizing vasculitis | A type of vasculitis that is comprised of vasculitides that present with necrosis. |
MONDO:0800114 | follicular bronchiolits | A polyclonal hyperplasia of bronchiolar associated lymphoid tissue characterized by the development of lymphoid follicles with germinal centers in walls of the small airways. |
MONDO:0800117 | cutaneous botryomycosis | A botromycosis that involves the skin and subcutaneous tissue (it is a more common type). |
MONDO:0800118 | visceral botryomycosis | A botryomycosis that involves internal organs such as lungs, liver, or brain. It is a rare disease and has been described mainly in patients with underlying diseases such as diabetes mellitus, cystic fibrosis, or HIV infection. It is most commonly affecting the lungs, although involvement of other organs including liver, spleen, kidney, and brain has also been described. |
MONDO:0800119 | postinfectious bronchiolitis obliterans | An irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection during childhood, especially early childhood. Although diagnosis of PIBO should be confirmed by histopathology, it is generally based on history and clinical findings. Irreversible airway obstruction is demonstrated by decreased forced expiratory volume in 1 second with an absent bronchodilator response, and by mosaic perfusion, air trapping, and/or bronchiectasis on computed tomography images. However, lung function tests using spirometry are not feasible in young children, and most cases of PIBO develop during early childhood. |
MONDO:0800120 | Mac-Leod-Swyer-James-Syndrome | A rare lung condidtion characterized by often predominantly unilateral lung hyperlucency and air trapping. The condition is a post-infectious form of bronchiolitis obliterans and typically follows a viral respiratory infection in infancy and childhood. Adenovirus infection is considered the most usual epidemiology. In SJS, the involved lung or portion of the lung does not grow normally and is slightly smaller than the opposite lung: in particular, peripheral branches of the pulmonary vessels do not develop, and vasculature is arreseted at the stage at which the infection occurred. Patients respond well to management with bronchodilators, even though this is not primarily a bronchial abnormality. |
MONDO:0800121 | cellular interstitial pneumonitis | An interstitial lung disease specific to infancy that is characterized by tachypnea at birth and persistent disease, diffuse interstitial thickening due to pale oval and spindle-shaped histiocytes without scarring. |
MONDO:0800123 | bronchiolocentric pattern of interstitial pneumonia | An interstitial lung disease characterized histologically by fibrosis and/or inflammation confined to the alveolar interstitium around bronchovascular bundles, overlapping with peribronchial metaplasia, fibrosis in some series and the lack of interstitial granulomas. |
MONDO:0800124 | Lane Hamilton syndrome | A rare concurrent association of idiopathic pulmonary hemosiderosis and celiac disease, and is typically seen in children under the age of 15. |
MONDO:0800125 | disseminated visceral giant cell angiitis | A necrotizing vasculitis characterized by widespread small-vessel giant cell angitis and extravascular granulomas. |
MONDO:0800126 | dystrophic pulmonary ossification | A rare lung disorder characterized by ectopic bone formation within lung parenchyma. DPO can be idiopathic or associated with a variety of cardiovascular, respiratory diseases or other disorders. There are mainly two forms of DPO: nodular and dendriform. |
MONDO:0800127 | pulmonary amyloidosis | A rare hereditary amyloidosis that incorporates deposition of amyloid microfibril material in the lung parenchyma. |
MONDO:0800128 | combined immunodeficiency due to POLE2 deficiency | Any combined immunodeficiency due to a deficiency in the POLE2 gene. |
MONDO:0800129 | autoinflammatory disease, X-linked | An autoinflammatory syndrome characterized by the onset of systemic autoinflammation in the first months of life. Features include lymphadenopathy, hepatosplenomegaly, fever, panniculitis, and nodular skin rash. Additional manifestations may include inflammation of the optic nerve, intracranial hemorrhage, and lipodystrophy. |
MONDO:0800130 | autoinflammatory syndrome with immunodeficiency | An autoinflammatory syndrome characterized by onset of various autoimmune features usually in the first decades of life, although later onset has been reported. Typical features include autoimmune cytopenia, hemolytic anemia, thrombocytopenia, and lymphadenopathy. More variable features may include autoimmune thyroiditis, psoriasis or eczema, nephritis, hepatitis, and symptoms of systemic lupus erythematosus (SL). Some patients may have recurrent infections or exacerbation of the disease with acute infection. Laboratory studies show variable findings, often decreased numbers of naive B cells, lymphopenia with skewed subsets, hypogammaglobulinemia, presence of autoantibodies, and a hyperinflammatory state. The disorder shows autosomal dominant inheritance with incomplete penetrance. |
MONDO:0800131 | hyper-IgE recurrent infection syndrome 4A, autosomal dominant | An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling. |
MONDO:0800132 | autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency | An autosomal recessive disorder characterized by severe anemia and thrombocytopenia apparent from early infancy, hepatosplenomegaly, and recurrent fevers associated with a hyperinflammatory state. Additional systemic features may include chronic diarrhea, proteinuria with renal disease, liver fibrosis with elevated liver enzymes, deforming arthropathy, and vasculitic skin lesions. Some patients may have motor delay or learning difficulties associated with subcortical white matter lesions on brain imaging. Laboratory studies show increased levels of proinflammatory cytokines and increased expression of interferon-stimulated genes (ISGs), consistent with a type I interferonopathy. |
MONDO:0800133 | pulmonary hypoplasia | A respiratory malformation characterized by the presence of both bronchi (albeit rudimentary) and alveoli in an under-developed lobe. Both the size and the weight of the lung are reduced. The true prevalence is not well known (1.4% of all births according to Knox et al. 13), but in cases of premature rupture of membranes at 15-28 weeks gestation, the reported prevalence of pulmonary hypoplasia ranges from 9 to 28%. Factors that contribute to pulmonary hypoplasia include adequate volume of the thoracic cavity, pulmonary fluid dynamics, and abnormal fetal breathing movements. |
MONDO:0800174 | encephalitis, acute, infection-induced, susceptibility to | An inherited susceptibility or predisposition to developing encephalitis, acute, infection-induced. |
MONDO:0800175 | cardiogenic shock | A rare, cardiac condition characterized by severely decreased cardiac output, hypoperfusion and end-organ dysfunction, in the presence of adequate intravascular volume. The clinical presentation is variable and may range from subtle hemodynamic alterations to overt cardiovascular collapse. Commonly reported features include dyspnea,... |
v2022-10-03
Overview:
- Number of new terms: 34
- Number of changed labels: 47
- Number of changed definitions: 7
- Number obsoleted terms: 10
- Number of new obsoletion candidates: 4
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100478 | brain malformations with or without urinary tract defects | A brain disorder caused by pathogenic variants in NFIA that is characterized by developmental delay, corpus callosum agenesis/hypoplasia and craniofacial dysmorphism, such as macrocephaly (caused by hydrocephalus or ventriculomegaly), low-set ears, anteverted nostrils and micrognathia. Urinary tract defects (e.g. vesicoureteral reflux, urinary incontinence) are also frequently associated. Other reported variable manifestations include hypotonia, tethered spinal cord, Chiari type I malformation and seizures. |
MONDO:0100500 | Mendelian neurodevelopmental disorder | A neurodevelopmental disorder that is caused by genetic modifications where those modifications are inherited from a parent's genome. |
MONDO:0700096 | human disease or disorder | |
MONDO:0700098 | neoplasm, non-human animal | |
MONDO:0700099 | adenocarcinoma, non-human animal | |
MONDO:0700100 | leukemia, non-human animal | |
MONDO:0700101 | carcinoma, non-human animal | |
MONDO:0700102 | lymphoma, non-human animal | |
MONDO:0700103 | nutritional deficiency disease, non-human animal | |
MONDO:0700104 | respiratory system disorder, non-human animal | |
MONDO:0700105 | difference of sexual differentiation, non-human animal | |
MONDO:0700106 | immune system disorder, non-human animal | |
MONDO:0700108 | prion disease, non-human animal | |
MONDO:0700109 | skin disease caused by bacterial infection, non-human animal | |
MONDO:0700110 | pneumonia, non-human animal | |
MONDO:0700111 | bacterial pneumonia, non-human animal | |
MONDO:0800103 | COACH syndrome 1 | Any COACH syndrome in which the cause of the disease is a variation in the TMEM67 gene. |
MONDO:0800134 | primary immunodeficiency due to calcium channel deficiency | An immunodeficiency disease caused by a variation in the CRACR2A gene. |
MONDO:0800135 | congenital emphysematous lung disease due to Filamin A loss-of-function variant | Any interstitial lung disease specific to childhood caused by a loss-of-function variation in the FLNA gene. Female children are reported more often. Rare male patients with loss-of-function FLNA mutation-associated lung disease with residual protein function can survive into infancy with a severe form of the phenotype. |
MONDO:0800136 | non-severe combined immunodeficiency due to COPG1 deficiency | Any non-severe combined immunodeficiency caused by a deficiency in the COPG1 gene. |
MONDO:0800137 | early-onset pulmonary and cutaneous vasculitis | A monogenic autoinflammatory disorder caused by a de novo activating mutation, p.Tyr515∗, in hematopoietic cell kinase (HCK). The disease is characterized by cutaneous vasculitis and chronic pulmonary inflammation that progresses to fibrosis. |
MONDO:0800138 | multisystem autoimmune disease due to IKAROS gain of function | An autoimmune disease caused by a loss-of-function variation in the IKZF1/IKAROSgene. Leukocytes of patients exhibited specific defects including impaired IL-2 production by T cells, T helper (TH) skewing toward TH2, low numbers of regulatory T cells (Treg), eosinophilia, and abnormal PC proliferation. |
MONDO:0800139 | HELIOS deficiency | A non-severe combined immunodeficiency caused by a loss-of-function variation in the IKZF2 gene that is characterized by recurrent upper respiratory infections, thrush and mucosal ulcers, and chronic lymphadenopathy. |
MONDO:0800140 | ITPKB deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the ITPKB gene. |
MONDO:0800141 | MAN2B2 deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the MAN2B2 gene. |
MONDO:0800142 | chronic mucocutaneous candidiasis and connective tissue disease due to JNK1 haploinsufficiency | An immunodeficiency disease caused by a variation in MAPK8, the gene encoding c-Jun N-terminal kinase 1 (JNK1), that is characterized by chronic mucocutaneous candidiasis and a connective tissue disorder that clinically overlaps with Ehlers-Danlos syndrome (EDS). |
MONDO:0800143 | cytomegalovirus pneumonia due to NOS2 deficiency | Cytomegalovirus pneumonia due to variant in the NOS2 gene. |
MONDO:0800144 | autoimmune pulmonary disease due to PD-1 deficiency | An autoimmune disease that is characterized by a lack of PD-1 on patient peripheral blood mononuclear cells (PBMCs) and reduced IFN production in response to mycobacterial stimuli. |
MONDO:0800145 | non-severe combined immunodeficiency due to polymerase delta deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the POLD1/POLD2 gene. |
MONDO:0800146 | agammaglobulinemia, autosomal recessive, due to BOB1 deficiency | Any agammaglobulinemia in which the cause of the disease is autosomal recessive deficiency in the BOB1 gene. |
MONDO:0800147 | hemophagocytic lymphohistiocytosis due to RhoG deficiency | Any genetic hemophagocytic lymphohistiocytosis in which the cause of the disease is an autosomal recessive variation in the RHOG gene. |
MONDO:0800148 | autoinflammatory syndrome due to TBK1 deficiency | Any autoinflammatory syndrome in which the cause of the disease is an autosomal recessive variation in the TBK1 gene. |
MONDO:0800149 | immunodeficiency, common variable, due to APRIL deficiency | Any commonn variable immunodeficiency in which the cause of the disease is an autosomal recessive variation in the TNFS13 gene. |
MONDO:0810000 | choroidal neovascularization | An eye disorder described by the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space. Choroidal neovascularization (CNV) is a major cause of visual loss. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0001571 | gynecomastia disorder | gynecomastia | gynecomastia disorder |
MONDO:0002145 | disorder of sexual differentiation | difference of sexual differentiation | disorder of sexual differentiation |
MONDO:0005272 | myelodysplastic syndrome with single lineage dysplasia | refractory anemia | myelodysplastic syndrome with single lineage dysplasia |
MONDO:0019453 | myelodysplastic syndrome with multilineage dysplasia | refractory cytopenia with multilineage dysplasia | myelodysplastic syndrome with multilineage dysplasia |
MONDO:0007925 | myelodysplastic syndrome associated with isolated del(5q) | chromosome 5q deletion syndrome | myelodysplastic syndrome associated with isolated del(5q) |
MONDO:0008907 | PMM2-congenital disorder of glycosylation | PMM2-CDG | PMM2-congenital disorder of glycosylation |
MONDO:0008908 | MGAT2-congenital disorder of glycosylation | MGAT2-CDG | MGAT2-congenital disorder of glycosylation |
MONDO:0012117 | ALG9-congenital disorder of glycosylation | ALG9-CDG | ALG9-congenital disorder of glycosylation |
MONDO:0010478 | SLC35A2-congenital disorder of glycosylation | SLC35A2-CDG | SLC35A2-congenital disorder of glycosylation |
MONDO:0010490 | SSR4-congenital disorder of glycosylation | SSR4-CDG | SSR4-congenital disorder of glycosylation |
MONDO:0010998 | ALG3-congenital disorder of glycosylation | ALG3-CDG | ALG3-congenital disorder of glycosylation |
MONDO:0011257 | MPI-congenital disorder of glycosylation | MPI-CDG | MPI-congenital disorder of glycosylation |
MONDO:0011291 | ALG6-congenital disorder of glycosylation 1C | congenital disorder of glycosylation type 1C | ALG6-congenital disorder of glycosylation 1C |
MONDO:0011342 | SLC35A1-congenital disorder of glycosylation | SLC35A1-CDG | SLC35A1-congenital disorder of glycosylation |
MONDO:0011629 | MOGS-congenital disorder of glycosylation | MOGS-CDG | MOGS-congenital disorder of glycosylation |
MONDO:0011772 | B4GALT1-congenital disorder of glycosylation | B4GALT1-CDG | B4GALT1-congenital disorder of glycosylation |
MONDO:0011783 | ALG12-congenital disorder of glycosylation | ALG12-CDG | ALG12-congenital disorder of glycosylation |
MONDO:0011933 | ALG2-congenital disorder of glycosylation | ALG2-CDG | ALG2-congenital disorder of glycosylation |
MONDO:0011964 | DPAGT1-congenital disorder of glycosylation | DPAGT1-CDG | DPAGT1-congenital disorder of glycosylation |
MONDO:0011969 | ALG8-congenital disorder of glycosylation | ALG8-CDG | ALG8-congenital disorder of glycosylation |
MONDO:0012041 | familial adenomatous polyposis 2 | MUTYH-related attenuated familial adenomatous polyposis | familial adenomatous polyposis 2 |
MONDO:0012052 | ALG1-congenital disorder of glycosylation | ALG1-CDG | ALG1-congenital disorder of glycosylation |
MONDO:0012118 | COG7-congenital disorder of glycosylation | COG7-CDG | COG7-congenital disorder of glycosylation |
MONDO:0012128 | transposition of the great arteries, dextro-looped | dextro-looped transposition of the great arteries 1 | transposition of the great arteries, dextro-looped |
MONDO:0012211 | MPDU1-congenital disorder of glycosylation | MPDU1-CDG | MPDU1-congenital disorder of glycosylation |
MONDO:0012556 | DK1-congenital disorder of glycosylation | DK1-CDG | DK1-congenital disorder of glycosylation |
MONDO:0012635 | COG8-congenital disorder of glycosylation | COG8-CDG | COG8-congenital disorder of glycosylation |
MONDO:0012637 | COG1-congenital disorder of glycosylation | COG1-CDG | COG1-congenital disorder of glycosylation |
MONDO:0012783 | RFT1-congenital disorder of glycosyla... |
v2022-09-06
Overview:
- Number of new terms: 19
- Number of changed labels: 15
- Number of changed definitions: 70
- Number obsoleted terms: 42
- Number of new obsoletion candidates: 5
- Number of terms who were previously candidate for obsoletion and are now not anymore: 43
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100434 | chronic mountain sickness | A pathological condition resulting from chronic exposure to hypoxia at high altitude. The syndrome is characterized by an excessive number of red blood cells associated with a high blood hemoglobin concentration ([Hb]), hypoxemia, and, in some cases, pulmonary hypertension. Clinical signs include headache, fatigue, sleep disturbances, dyspnea, digestive complaints, and high risk of thrombotic events. |
MONDO:0100440 | Asperger syndrome, susceptibility to | An inherited susceptibility or predisposition to developing Asperger sydrome. |
MONDO:0100473 | disorder of peptide and amine metabolism | An inherited metabolic disease that has its basis in the disruption of peptide and/or amine metabolic process. |
MONDO:0100477 | disorder of methylamine metabolism | An inherited metabolic disease that has its basis in the disruption of methylamine metabolic process. |
MONDO:0100509 | IFT140-related recessive ciliopathy | Any ciliopathy in which the cause of the disease is biallelic variants in the IFT140 gene. |
MONDO:0100510 | spondyloepimetaphyseal dysplasia | An osteochondrodysplasia that results in abnormalities of bone growth in the vertebral column, epiphysis, and metaphysis. |
MONDO:0100514 | familial ovarian carcinoma | Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma. |
MONDO:0100515 | mirror movements 1 and/or agenesis of the corpus callosum | A familial congenital mirror movement disorder where individuals with heterozygous variants in DCC have congenital mirror movements and/or agenesis of the corpus callosum (not with or without- some individuals do not demonstrate mirror movements and only have corpus callosum defects, even within the same family). |
MONDO:0100516 | complex neurodevelopmental disorder with motor features | A complex neurodevelopmental disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy). Additionally, the disorder features at least one phenotype associated with motor function, including but not limited to spasticity, hypo- or hypertonia, dyskinesia, choreo-athetosis, or ataxia. |
MONDO:0800107 | anterior deviation infundibular septum | |
MONDO:0800108 | cleft leaflet of tricuspid valve | |
MONDO:0800152 | disorder of galactose and fructose metabolism | An inherited disorder of carbohydrate metabolism that is has its basis in the disruption of galactose and/or fructose metabolic process. |
MONDO:0800153 | urea cycle disorder or inherited hyperammonemia | A disorder of amino acid metabolism that has its basis in the disruption of the urea cycle and/or there is an inherited increased concentration of ammonia in the blood. |
MONDO:0800154 | inborn disorder of the metabolism of sulfur-containing amino acids and hydrogen sulfide | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of sulfur-containing amino acids and/or hydrogen sulfide. |
MONDO:0800155 | inborn disorder of glycine and serine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glycine and/or serine. |
MONDO:0800156 | inborn disorder of ornithine, proline and hydroxyproline metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of ornithine, proline and/or hydroxyproline. |
MONDO:0800157 | inborn disorder of lysine, hydroxylysine, and tryptophan metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of lysine, hydroxylysine, and/or tryptophan. |
MONDO:0800158 | inborn disorder of glutamate/glutamine and aspartate/asparagine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glutamate/glutamine and aspartate/asparagine. |
MONDO:0800159 | disorder of polyamine metabolism | An inherited metabolic disease that has its basis in the disruption of the polyamine metabolic process. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0004736 | inborn disorder of amino acid metabolism | inherited amino acid metabolic disorder | inborn disorder of amino acid metabolism |
MONDO:0000688 | inborn organic aciduria | inherited organic acidemia | inborn organic aciduria |
MONDO:0002412 | disorder of glycogen metabolism | glycogen storage disease | disorder of glycogen metabolism |
MONDO:0019216 | inborn disorder of amino acid transport | inborn disorder of amino acid absorption and transport | inborn disorder of amino acid transport |
MONDO:0017706 | disorder of carbohydrate transmembrane transport and absorption | disorder of carbohydrate absorption and transport | disorder of carbohydrate transmembrane transport and absorption |
MONDO:0019225 | disorder of gluconeogenesis | gluconeogenesis disorder | disorder of gluconeogenesis |
MONDO:0010078 | spondyloperipheral dysplasia | spondyloperipheral dysplasia-short ulna syndrome | spondyloperipheral dysplasia |
MONDO:0010888 | adenomyosis | endometriosis of uterus | adenomyosis |
MONDO:0016200 | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase - | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
MONDO:0014502 | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency |
MONDO:0016182 | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase |
MONDO:0016454 | Charcot-Marie-Tooth disease type 2B5 | severe early-onset axonal neuropathy due to NEFL deficiency | Charcot-Marie-Tooth disease type 2B5 |
MONDO:0019235 | inborn disorder of phenylalanine and tyrosine metabolism | inborn disorder of phenylalanin or tyrosine metabolism | inborn disorder of phenylalanine and tyrosine metabolism |
MONDO:0019223 | disorder of fatty acid and ketone body metabolism | inborn disorder of fatty acid oxidation and ketone body metabolism | disorder of fatty acid and ketone body metabolism |
MONDO:0017900 | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000155 | triglyceride storage disease | An acquired metabolic disease that is has its basis in the disruption of sequestering of triglyceride. | An inherited metabolic disease that is has its basis in the disruption of sequestering of triglyceride. |
MONDO:0019226 | glucose transport disorder | An acquired metabolic disease that is has its basis in the disruption of glucose transport. | An inherited metabolic disease that is has its basis in the disruption of glucose transport. |
MONDO:0000273 | Kunjin virus infectous disease | A West Nile encephalitis that results in infection located in brain, has material basis in Kunjin virus, a subtype of West Nile Virus, which is transmitted by Culex annulirostris mosquito bite. The infection has symptom fever, has symptom rigor, has symptom headache, has symptom confusion, and has symptom lethargy. | |
MONDO:0000351 | disorder of methionine catabolism | An acquired metabolic disease that is has its basis in the disruption of methionine catabolic process. | An inherited metabolic disease that is has its basis in the disruption of methionine catabolic process. |
MONDO:0019222 | inborn disorder of methionine cycle and sulfur amino acid metabolism | An acquired metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. |
MONDO:0037938 | inborn disorder of aspartate family metabolism | An acquired metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. |
MONDO:0000421 | inborn serine deficiency | An acquired metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. |
MONDO:0019239 | inborn disorder of serine family metabolism | An acquired metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. |
MONDO:0005528 | inborn vitamin metabolic disorder | An acquired metaboli... |
v2022-08-01
Overview:
- Number of new terms: 19
- Number of changed labels: 6
- Number of changed definitions: 35
- Number obsoleted terms: 34
- Number of new obsoletion candidates: 34
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0030827 | macrothrombocytopenia, isolated, 2, autosomal dominant | |
MONDO:0030839 | thyroid hormone metabolism, abnormal, 2 | |
MONDO:0031432 | thyroid hormone metabolism, abnormal | |
MONDO:0031447 | macrothrombocytopenia, isolated | |
MONDO:0100498 | UROD-related inherited porphyria | Any inherited porphyria in which the cause of the disease is monoallelic or biallelic variants in the UROD gene. |
MONDO:0100502 | NTHL1-deficiency tumor predisposition syndrome | Biallelic constitutional/germline loss-of-function NTHL1 variants confer predisposition to tumor formation demonstrating ‘COSMIC Signature 30’ mutation profile. Tumors have been reported at multiple primary sites; in particular adenomatous polyposis of colon (~10-50 polyps), colorectal cancer, and breast cancer. |
MONDO:0100503 | DPH5-related diphthamide-deficiency syndrome | A neurodevelopmental disorder in which the cause of the disease is a mutation in the DPH5 gene, which is characterized by craniofacial dysmorphology, profound neurodevelopmental delay, multisystem abnormalities, and miscarriages. |
MONDO:0100504 | fungal infection of the toenail | A fungal infectious disease that involves the toenail. |
MONDO:0100505 | food dermatitis | Dermatitis caused by an allergic reaction to ingested food. |
MONDO:0100506 | Cockayne spectrum with or without cerebrooculofacioskeletal syndrome | An autosomal recessive, multisystem condition caused by pathogenic variants of the ERCC6 gene, encoding the DNA excision repair protein, ERCC-6. Cockayne spectrum with or without cerebrooculofacioskeletal syndrome is characterized by growth failure at birth, with little or no postnatal neurologic development in addition to congenital cataracts or other structural anomalies of the eye, early postnatal contractures of the spine (kyphosis, scoliosis) and joints, and death usually occurring by age five years. This term lumps Cockayne syndrome type 2/B (CSB), cerebrooculofacioskeletal syndrome 1 (COFS syndrome), and De Sanctis-Cacchione syndrome into a spectrum of disease. |
MONDO:0700082 | Robertsonian translocation Down syndrome | Chromosomal disorder in which (part or full) chromosome 21 is attached to another chromosome, resulting in the presence of a third copy of part of full chromosome 21 genetic material. A Robertsonian translocation is a structural chromosomal anomaly in which two acrocentric chromosomes break, resulting in the fusion of the nonhomologous chromosomes’ long arms to form a single, large chromosome. |
MONDO:0700083 | reciprocal translocation down syndrome | Chromosomal disorder in which (part or full) chromosome 21 has been exchange with another chromosome, resulting in the presence of a third copy of (part or full) chromosome 21 genetic material. A reciprocal translocation is a chromosome abnormality caused by exchange of parts between non-homologous chromosomes. |
MONDO:0700093 | balanced Robertsonian translocation Down syndrome | Robertsonian translocation Down syndrome in which translocation displacement of the end regions of chromosomes occured without loss of chromosomal material between the two nonhomologous chromosomes. |
MONDO:0700094 | unbalanced Robertsonian translocation Down syndrome | Robertsonian translocation Down syndrome in which translocation displacement of the end regions of chromosomes occured with loss of chromosomal material between the two nonhomologous chromosomes. |
MONDO:0800046 | thyroid hormone metabolism, abnormal 1 | A rare, genetic congenital hypothyroidism disorder characterized by mild global developmental delay in childhood, short stature, delayed bone age, and abnormal thyroid and selenium levels in serum (high total and free T4 concentrations, low T3, high reverse T3, normal to high TSH, decreased selenium). Intellectual disability, primary infertility, hypotonia, muscle weakness, and impaired hearing have also been reported. |
MONDO:0800047 | macrothrombocytopenia, isolated, 1, autosomal dominant | Any autosomal dominant macrothrombocytopenia in which the cause of the disease is a mutation in the TUBB1 gene. |
MONDO:0800104 | immunodeficiency 105 | Any immunodeficiency disease which the cause of the disease is a mutation in the PTPRC gene. |
MONDO:0800105 | catatonia | A psychiatric disorder featuring stupor, posturing, and echophenomena. |
MONDO:0800106 | disruptive behavior disorder | A mental disorder that includes conduct disorder (CD), oppositional defiant disorder (ODD), and attention Deficit Hyperactivity Disorder (ADHD). Features may include frequent aggression, deceitfulness, and defiance, and often persist through the lifespan. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0007962 | megalodactyly | Megalodactyly | megalodactyly |
MONDO:0008075 | schwannomatosis | neurofibromatosis type 3 | schwannomatosis |
MONDO:0010663 | intellectual disability-hypotonic facies syndrome, X-linked, 1 | X-linked intellectual disability-hypotonic face syndrome | intellectual disability-hypotonic facies syndrome, X-linked, 1 |
MONDO:0012163 | immunodeficiency 104 | severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive | immunodeficiency 104 |
MONDO:0013784 | neonatal-onset encephalopathy with rigidity and seizures | lethal neonatal spasticity-epileptic encephalopathy syndrome | neonatal-onset encephalopathy with rigidity and seizures |
MONDO:0700130 | partial segmental duplication | partial trisomy 21 | partial segmental duplication |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0004598 | acute cor pulmonale | Acute form of cor pulmonale. | A form of acute right heart failure produced by a sudden increase in resistance to blood flow in the pulmonary circulation. |
MONDO:0017666 | diffuse palmoplantar keratoderma | Palmoplantar keratoderma that diffusely involves most of the palm and sole and is caused by a genetic abnormality. | |
MONDO:0007113 | Angelman syndrome | Angelman syndrome (AS) is a neurogenetic disorder characterized by severe intellectual deficit and distinct facial dysmorphic features. | A neurogenetic disorder characterized by severe intellectual deficit and distinct facial dysmorphic features. |
MONDO:0007168 | atelosteogenesis type III | Atelosteogenesis III (AOIII) is a skeletal dysplasia characterized by short limbs dysmorphic facies and diagnostic radiographic findings. | A skeletal dysplasia characterized by short limbs dysmorphic facies and diagnostic radiographic findings. |
MONDO:0016524 | congenital vascular bone syndrome | An alteration in limb growth caused by congenital vascular malformations in childhood | An alteration in limb growth caused by congenital vascular malformations in childhood. |
MONDO:0019270 | erythrokeratoderma | An umbrella term for a group of rare genetic skin disorders characterized by well-demarcated plaques of reddened, dry and thickened skin. Typically, these lesions are distributed symmetrically on the body and tend to slowly expand and progress over time. | |
MONDO:0008608 | Down syndrome | Down syndrome is a chromosomal abnormality caused by the presence of a third (partial or total) copy of chromosome 21 and that is characterized by variable intellectual disability, muscular hypotonia, and joint laxity, often associated with a characteristic facial dysmorphism and various anomalies such as cardiac, gastrointestinal, or endocrine defects. | Down syndrome is a chromosomal abnormality caused by the presence of a third (partial or total) copy of the chromosome 21 genetic material and that is characterized by variable intellectual disability, muscular hypotonia, and joint laxity, often associated with a characteristic facial dysmorphism and various anomalies such as cardiac, gastrointestinal, or endocrine defects. |
MONDO:0008075 | schwannomatosis | Neurofibromatosis (NF) type 3 (NF3), also known as schwannomatosis, is the least frequent form of the rare genetic disorder neurofibromatosis. It is clinically and genetically distinct from NF1 and NF2 and is characterized by the development of multiple schwannomas (nerve sheath tumors), without involvement of the vestibular nerves. NF3 develops in adulthood and is often associated with chronic pain. Dysesthesia and paresthesia may also be present. Common localizations include the spine, peripheral nerves, and the cranium. | The least frequent form of the rare genetic disorder neurofibromatosis. It is clinically and genetically distinct from NF1 and NF2 and is characterized by the development of multiple schwannomas (nerve sheath tumors), without involvement of the vestibular nerves. NF3 develops in adulthood and is often associated with chronic pain. Dysesthesia and paresthesia may also be present. Common localizations include the spine, peripheral nerves, and the cranium. |
MONDO:0015104 | porphyria cutanea tarda | Porphyria cutanea tarda (PCT) is the most common form of chronic hepatic porphyria. It is characterized by bullous photodermatitis. | The most common form of chronic hepatic porphyria. It is characterized by bullous photodermatitis. |
MONDO:0008756 | alopecia - intellectual disability syndrome | Alopecia-intellectual deficit syndrome is an extremely rare syndrome described in less than 20 families to date and characterized by total or partial alopecia associated with intellectual deficit. The syndrome can be associated with other anomalies such as seizures,... |
v2022-07-01
Overview:
- Number of new terms: 100
- Number of changed labels: 17
- Number of changed definitions: 55
- Number obsoleted terms: 15
- Number of new obsoletion candidates: 120
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0024770 | autoinflammatory syndrome, familial, X-linked, Behcet-like 2 | |
MONDO:0024781 | immunodeficiency 102 | |
MONDO:0027652 | 5-fluorouracil toxicity | |
MONDO:0027653 | abacavir toxicity | |
MONDO:0027655 | allopurinol toxicity | |
MONDO:0027664 | cisplatin toxicity | |
MONDO:0027666 | codeine toxicity | |
MONDO:0027667 | efavirenz toxicity | |
MONDO:0027668 | flucloxacilline toxicity | |
MONDO:0027675 | irinotecan toxicity | |
MONDO:0027677 | isoniazid toxicity | |
MONDO:0027687 | raltegravir toxicity | |
MONDO:0027696 | voriconazole toxicity | |
MONDO:0030756 | Stuve-Wiedemann syndrome 2 | |
MONDO:0030770 | congenital disorder of deglycosylation 2 | |
MONDO:0030781 | restrictive dermopathy 2 | |
MONDO:0030881 | developmental and epileptic encephalopathy 102 | |
MONDO:0030886 | holoprosencephaly 14 | |
MONDO:0030887 | cardiomyopathy, dilated, 2G | |
MONDO:0030890 | pontocerebellar hypoplasia, IIA 17 | |
MONDO:0030891 | intellectual developmental disorder, autosomal dominant 66 | |
MONDO:0031213 | restrictive dermopathy | |
MONDO:0031257 | high altitude pulmonary edema | A rare pulmonary condition characterized by non-cardiogenic pulmonary edema occurring in otherwise healthy individuals within days of an ascent above 2500-3000 m. Early symptoms include exertional dyspnea, non-productive cough, chest tightness, and reduced exercise performance, followed by dyspnea at rest and possibly orthopnea, as well as gurgling in the chest and pink frothy sputum in advanced cases. Clinical signs are cyanosis, tachypnea, tachycardia, crackles or wheezing, and elevated body temperature (generally not exceeding 38.5°C). Signs of concomitant high-altitude cerebral edema may also be observed. Chest x-rays typically show patchy opacities predominantly in the right middle lobe. |
MONDO:0031280 | Stuve-Wiedemann syndrome | |
MONDO:0031376 | congenital disorder of deglycosylation | |
MONDO:0031384 | autoinflammatory syndrome, familial, Behcet-like | |
MONDO:0033169 | curariform drugs toxicity | |
MONDO:0033170 | statin toxicity | |
MONDO:0033181 | phenytoin or carbamazepine toxicity | |
MONDO:0033938 | acute radiation syndrome | |
MONDO:0034989 | intellectual disability-cardiac anomalies-short stature-joint laxity syndrome | A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by intrauterine and postnatal growth restriction, global developmental delay, intellectual disability, and dysmorphic facial features (such as broad nasal root, anteverted nares, long philtrum, low-set and posteriorly rotated ears, and short neck). Additional reported manifestations are microcephaly, short stature, vertebral abnormalities, joint laxity, ocular, cardiac, and renal defects, and minor limb anomalies. Brain imaging may show hypoplastic corpus callosum, delayed myelination, and cerebral atrophy. |
MONDO:0034991 | intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | A rare genetic disease characterized by the presence of multiple café-au-lait macules and elevated rates of sister chromatid exchange demonstrated on cytogenetic testing. Pre- and postnatal growth deficiency with short stature, microcephaly, mild developmental delay, cardiomyopathy, and symptomatic gastro-esophageal reflux have also been described, while malar rash is typically absent. |
MONDO:0035337 | Duane retraction syndrome with congenital deafness | A rare neurologic disease characterized by the presence of Duane retraction syndrome (i. e. a congenital cranial dysinnervation disorder with unilateral or bilateral limitation of abduction and/or adduction of the eye, as well as globe retraction and palpebral fissure narrowing on attempted adduction) in combination with congenital unilateral or bilateral hearing loss. The sidedness of hearing loss corresponds to the sidedness of the retraction syndrome. |
MONDO:0035344 | acute bilirubin encephalopathy | A rare neurologic disease characterized by lethargy, hypotonia, poor feeding, opisthotonus, and a typical high-pitched cry due to bilirubin accumulation in the globus pallidus, sub-thalamic nuclei, and other brain regions, resulting from severe neonatal unconjugated hyperbilirubinemia. Onset of symptoms is typically within the first three to five days of life. Additional features include fever, apnea, seizures, and coma. Especially respiratory failure or refractory seizures may lead to a fatal outcome. |
MONDO:0035345 | chronic bilirubin encephalopathy | A rare neurologic disease characterized by the chronic consequences of bilirubin toxicity in the globus pallidus, sub-thalamic nuclei, and other brain regions, after exposure to high levels of unconjugated bilirubin in the neonatal period. Symptoms begin after the acute phase of bilirubin encephalopathy in the first year of life, evolve slowly over several years, and include mild to severe extrapyramidal disturbances (especially dystonia and athetosis), auditory neuropathy spectrum disorder, and oculomotor and dental abnormalities. |
MONDO:0035350 | letrozole toxicity | |
MONDO:0035763 | idiopathic non-lupus full-house nephropathy | |
MONDO:0035764 | idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance | |
MONDO:0035777 | parenteral nutrition-associated cholestasis | A rare hepatic disease characterized by intrahepatic cholestasis and deterioration of liver function in patients receiving parenteral nutrition for extended periods of time (signs may appear as early as within the first two weeks of initiation of parenteral nutrition). The condition commonly occurs in neonates and usually resolves with transition to enteral feeding, although severe cases may progress to liver fibrosis, cirrhosis, and portal hypertension. |
MONDO:0035838 | idiopathic multicentric Castleman disease | |
MONDO:0035875 | ivermectin toxicity | |
MONDO:0035876 | belinostat toxicity or dose selection | |
MONDO:0035930 | neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency | |
MONDO:0035940 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | |
MONDO:0035941 | B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) | |
MONDO:0035942 | B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) | |
MONDO:0035943 | B-lymphoblastic leukemia/lymphoma with hyperdiploidy | |
MONDO:0035944 | B-lymphoblastic leukemia/lymphoma with hypodiploidy | |
MONDO:0035945 | B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) | |
MONDO:0036025 | toxicity to dolutegravir | |
MONDO:0036042 | KAT6B-related multiple congenital anomalies syndrome | |
MONDO:0036045 | euthyroid dysprealbuminemic hyperthyroxinemia | |
MONDO:0036189 | oculogastrointestinal-neurodevelopmental syndrome | |
MONDO:0036192 | EN1-related dorsoventral syndrome | |
MONDO:0036193 | parkinsonism with polyneuropathy | |
MONDO:0036212 | spastic paraparesis-cataracts-speech delay syndrome | |
MONDO:0036217 | lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to a point mutation | |
MONDO:0036218 | lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to biallelic deletions in the ATAD3 gene cluster | |
MONDO:0037149 | HSD10 disease, atypical type | |
MONDO:0037398 | pneumonia caused by pseudomonas aeruginosa infection | A rare pulmonary disease characterized by primary or nonbacteremic pneumonia most frequently arising in an intensive care setting, or bacteremic pneumonia, which is typically associated with neutropenia. Chronic lower respiratory tract infection with development of episodes of pneumonia is common in patients with cystic fibrosis. Acute infections are potentially life-threatening. Patients present with fever, chills, dyspnea, cyanosis, productive cough, as well as signs of severe systemic toxicity. Alveolar hemorrhage, necrosis, and, eventually, cavity formation, are commonly seen. |
MONDO:0100464 | acid sphingomyelinase deficiency | An autosomal recessive lysosomal disease caused by biallelic loss of function variants in the SMPD1 gene. Clinical symptoms in affected individuals occur along a continuum. At the severe end of the spectrum are individuals historically diagnosed with Niemann-Pick disease type A (the neurovisceral form), which is characterized by hepatosplenomegaly with rapid neurological deterioration leading to death in the first few years of life. At the milder end of the spectrum are individuals historically diagnosed with Niemann-Pick disease type B, a later-onset, chronic visceral form, characterized by progressive visceral organ symptoms including hepatosplenomegaly and pulmonary insufficiency, and survival into adulthood. In addition, some affected individuals present with an intermediate phenotype, Niemann-Pick disease type A/B. |
MONDO:0100465 | complex neurodevelopmental disorder with or without congenital anomalies | A complex neurodevelopmental disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy), in addition to one or more structural or functional anomaly(ies) that develops prenatally. |
MONDO:0100492 | Bonnevie-Ullrich syndrome | A genetic syndrome which occurs in females. It is caused by the inheritance of only one complete X chromosome (45, X). Clinical signs of the symmetrical form are identical to those of Turner syndrome and include bilateral webbin... |